Wegovy contains semaglutide, a human glucagon-like peptide-1 (GLP-1) analogue produced using recombinant DNA technology
Skovlund SE, Nicolucci A, Balk-Mller N et al (2021) Perceived benefits, barriers, and facilitators of a digital patient-reported outcomes tool for routine diabetes care: protocol for a national, multicenter, mixed methods implementation study
For tirzepatide or other formulations dosed weekly or twice weekly, your surgical team will specify the exact date to stop
Conversely, certain foods to avoid include greasy, high-fat options that slow gastric emptying further and worsen nausea
Measuring visceral adipose tissue metabolic activity in sleep apnea utilizing hybrid (18)F-FDG PET/MRI: a pilot study
Many people stay on maintenance doses indefinitely